Ng Teng Fong General Hospital (NTFGH) has unveiled Project ENTenna, an AI-driven initiative aimed at revolutionising the management of allergic rhinitis and other chronic diseases. This pioneering programme, supported by the Ministry of Health and JurongHealth Fund, will track 6,000 patients from 2024 to 2026, providing personalised treatment strategies and improving medication adherence.
Project ENTenna establishes Asia’s first comprehensive AI-driven allergic diseases database, focusing on allergic rhinitis. The initiative integrates patient demographics, clinical notes, and symptom trends to offer insights into personalised patient management. Adjunct Associate Professor Ng Chew Lip, the principal investigator, highlighted the project’s potential to transform chronic disease management across Asia.
Preliminary findings from 1,000 patients indicate significant improvements: reduced 630 repeat visits in hospital clinics and a 45% increase in transitioning patients to primary care. AI-powered tools, including avatars and symptom trackers, have boosted treatment adherence by 25%.
The programme also explores biomolecular treatments, recognising the unique allergy patterns in Asians compared to Caucasians. Collaborating with A*STAR, the project aims to identify new therapeutic targets and understand varying patient responses to standard treatments.
Future plans for Project ENTenna include expanding into paediatric care and enhancing outreach to vulnerable groups, such as migrant workers. The initiative also aims to extend its platform to other chronic diseases, including dementia and stroke, fostering a comprehensive, data-driven healthcare ecosystem in Singapore and beyond.
“`
